Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Oncotarget|April 15, 2017
Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosisShuting Li, Yanwei Shen, Mengying Wang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 17, 2016
Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancerJiao Yang, Shuting Li, Biyuan Wang, et al.Plos One|June 24, 2017
Tumor location as a novel high risk parameter for stage II colorectal cancersBiyuan Wang, Jiao Yang, Shuting Li, et al.International Journal of Biological Sciences|June 29, 2017
Angiomotin Family Members: Oncogenes or Tumor Suppressors?Meng Lv, Yanwei Shen, Jiao Yang, et al.Surgical Endoscopy|July 19, 2019
Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survivalKe Chen, Yucheng Zhou, Weiwei Jin, et al.Frontiers in Pharmacology|October 29, 2020
Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature ReviewMingxing Wang, Yunyun Xu, Min Yang, et al.Frontiers in Oncology|December 6, 2021
A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisXiaochen Chen, Huafeng Qiu, Yunwang Chen, et al.Cell Death & Disease|February 23, 2019
Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancerJiao Yang, Xiaoman Zhang, Zheling Chen, et al.Oncotargets and Therapy|March 30, 2017
Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort studyJiao Yang, Shuting Li, Meng Lv, et al.Oncotarget|September 17, 2017
Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancerYanwei Shen, Jianfeng Quan, Mengying Wang, et al.Pageof 4